Prostate MR Imaging in 2011: Current Role in Staging and Surveillance; Nov. 28, 8:30am-10:00am

A team of researchers will review the basics of prostate MR imaging, including the limitations of current therapeutic approaches; prostate cancer care guidelines; indications for prostate MR imaging and its role in diagnosis, management and biopsy.

When: Monday, Nov. 28, 8:30-10:00am
Where: S406B

Speaker information:
Peter L. Choyke, MD, chief senior clinician molecular imaging, National Cancer Institute, Bethesda, Md.
Masoom Haider, MD, clinician scientist, Ontario Institute for Cancer Research, Toronto
Neil M. Rofsky, MD, chief MRI, Beth Israel Deaconess Medical Center, Boston

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.